Skip to content

Preview

Will China join the Emerging Market recovery?

2023 saw the beginning of a recovery in Emerging Markets (EM) but China continues to lag behind. The MSCI EM ex China delivered a year-to-date return of 10.0%, while MSCI China is down 11.0% in the same period.1 This compares to MSCI ACWI at 14.7%2 or the S&P 500 at 24.3%3. Generally speaking, fundamentals look healthy and, when combined with extremely compelling valuations, we see great potential in the EM asset class.

In this paper, Martin Currie consider China is at a unique turning point where all the following five points are directionally positive:

  1. Fundamentals
  2. Valuation
  3. Positioning
  4. Politics
  5. Policy

This is a powerful combination and Martin Currie believes it places EM companies and countries in a strong position. They are set to benefit from strong earnings growth, attractive valuation, a supportive fiscal and political environment and the prospect of a potential normalisation in global/EM asset allocations.

Martin Currie is excited to see how companies and the market respond to this favourable environment in 2024.



IMPORTANT LEGAL INFORMATION

Information on this website is intended to be of general information only and does not constitute investment or financial product advice. It expresses no views as to the suitability of the products or services described as to the individual circumstances, objectives, financial situation, or needs of any investor. You should conduct your own investigation or consult a financial adviser before making any decision to invest. Please read the relevant Product Disclosure Statements (PDSs), and any associated reference documents before making an investment decision.

Neither Franklin Templeton Australia, nor any other company within the Franklin Templeton group guarantees the performance of any Fund, nor do they provide any guarantee in respect of the repayment of your capital. In accordance with the Design and Distribution Obligations, we maintain Target Market Determinations (TMD) for each of our Funds. All documents can be found via the Literature Page or by calling 1800 673 776. 

CFA® and Chartered Financial Analyst® are trademarks owned by CFA Institute.